Molecular therapy for Cancer: Anti-cancer drug Campothecin (CPT) suppresses the expression of BANF1 via up regulation of its target gene, 07/February/2015, 23.29

Molecular therapy for Cancer: Anti-cancer drug Campothecin (CPT) suppresses the expression of BANF1 via up regulation of its target gene, 07/February/2015, 23.29

Molecular therapy for Cancer: Anti-cancer drug Campothecin (CPT) suppresses the expression of BANF1 via up regulation of its target gene, 07/February/2015, 23.29 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Molecular therapy for Cancer: Anti-cancer drug Campothecin (CPT) suppresses the expression of BANF1 via up regulation of its target gene, 07/February/2015, 23.29, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that Campothecin (CPT), by increasing the expression of its target gene, it may suppress the expression of BANF1.  Thus, pharmacological formulations encompassing “Campothecin  or its analogues  may be used to inhibit the progression of tumors.

Amount: $ 300

Undisclosed information: How Campothecin (CPT) suppresses the expression of BANF1

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org